These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28531832)

  • 1. Fighting falsified medicines: The analytical approach.
    Rebiere H; Guinot P; Chauvey D; Brenier C
    J Pharm Biomed Anal; 2017 Aug; 142():286-306. PubMed ID: 28531832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Falsification of biotechnology drugs: current dangers and/or future disasters?
    Janvier S; De Spiegeleer B; Vanhee C; Deconinck E
    J Pharm Biomed Anal; 2018 Nov; 161():175-191. PubMed ID: 30165334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current challenges in the detection and analysis of falsified medicines.
    Bakker-'t Hart IME; Ohana D; Venhuis BJ
    J Pharm Biomed Anal; 2021 Apr; 197():113948. PubMed ID: 33582458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benchtop low-field
    Assemat G; Balayssac S; Gerdova A; Gilard V; Caillet C; Williamson D; Malet-Martino M
    Talanta; 2019 May; 196():163-173. PubMed ID: 30683346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benchtop NMR spectroscopy in the analysis of substandard and falsified medicines as well as illegal drugs.
    Keizers PHJ; Bakker F; Ferreira J; Wackers PFK; van Kollenburg D; van der Aa E; van Beers A
    J Pharm Biomed Anal; 2020 Jan; 178():112939. PubMed ID: 31672579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inorganic analysis of falsified medical products using X-ray fluorescence spectroscopy and chemometrics.
    Rebiere H; Kermaïdic A; Ghyselinck C; Brenier C
    Talanta; 2019 Apr; 195():490-496. PubMed ID: 30625574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
    Pashkov V; Soloviov A; Olefir A
    Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raman chemical imaging for spectroscopic screening and direct quantification of falsified drugs.
    Rebiere H; Martin M; Ghyselinck C; Bonnet PA; Brenier C
    J Pharm Biomed Anal; 2018 Jan; 148():316-323. PubMed ID: 29080412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The health consequences of falsified medicines- A study of the published literature.
    Rahman MS; Yoshida N; Tsuboi H; Tomizu N; Endo J; Miyu O; Akimoto Y; Kimura K
    Trop Med Int Health; 2018 Dec; 23(12):1294-1303. PubMed ID: 30291683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Are there counterfeit medicines in Croatia?].
    Tomić S; Milcić N; Sokolić M; Sucić AF; Martinac AI
    Lijec Vjesn; 2010; 132(3-4):81-6. PubMed ID: 20540433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market.
    Janvier S; Cheyns K; Canfyn M; Goscinny S; De Spiegeleer B; Vanhee C; Deconinck E
    Talanta; 2018 Oct; 188():795-807. PubMed ID: 30029448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey on illegal and counterfeit medicines for the treatment of erectile dysfunctions in Italy.
    Gaudiano MC; Manna L; Rodomonte AL; Bartolomei M; Bertocchi P; Gallinella B; Antoniella E; Muleri N; Civitelli G; Alimonti S; Romanini L; Rufini L; Valvo L
    J Sex Med; 2012 Aug; 9(8):2130-7. PubMed ID: 22612848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FALSIFICATION OF MEDICINES AND DISTRIBUTION OF FALSIFIED MEDICINES IN UKRAINE: CRIMINALISTIC MEANS OF DETECTION AND COUNTERACTION.
    Shevchuk VM; Parfylo IV; Sokolenko MO
    Wiad Lek; 2021; 74(11 cz 2):2946-2953. PubMed ID: 35029561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Herceptin® case : A case of falsification of medicinal products to a greater extent].
    Streit R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1203-1207. PubMed ID: 28936679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding and fighting the medicine counterfeit market.
    Dégardin K; Roggo Y; Margot P
    J Pharm Biomed Anal; 2014 Jan; 87():167-75. PubMed ID: 23384475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SALE OF FALSIFIED MEDICINES VIA THE INTERNET IN UKRAINE: PROBLEMS OF DETECTION AND COUNTERACTION.
    Grynko L; Chornyi H; Kostenko M
    Wiad Lek; 2023; 76(5 pt 1):1106-1112. PubMed ID: 37326096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Task force for falsified medicines].
    Weber G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1240-1244. PubMed ID: 28905078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plague of unexpected drug recalls and the pandemic of falsified medications in cardiovascular medicine as a threat to patient safety and global public health: A brief review.
    Świeczkowski D; Zdanowski S; Merks P; Szarpak Ł; Vaillancourt R; Jaguszewski MJ
    Cardiol J; 2022; 29(1):133-139. PubMed ID: 33346374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.